why choose us

First received: March 26, 2024

Clinical Trial: RE104 Safety and Efficacy Study in Postpartum Depression

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Postpartum Depression

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)

Brief Summary: The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms in participants with moderate-to-severe postpartum depression (PPD) as compared to active-placebo.

Read more